Biopharma
Emergent Netherlands B.V.
Former vaccine holder — travel health
Historical catalogue identity. See the official sources and each product page for the documented operator.
No current official website has been confirmed. The public sources consulted are listed below.
About Emergent Netherlands B.V.
Emergent Netherlands B.V. is a vaccine authorisation holder identity documented by the European Medicines Agency for Vivotif. This reference explains the catalogue name.
Emergent’s annual report records the sale of its travel health business, including rights to Vivotif and Vaxchora, to Bavarian Nordic on 15 May 2023. This business transfer does not establish that the two companies are the same legal entity.
Official sources
- EMA — titulaire Emergent Netherlands B.V. pour Vivotif
- Emergent — cession de l’activité santé des voyageurs en mai 2023
Information checked 10 November 2026
Associated catalogue products
These products are linked to this organisation in the catalogue as a laboratory or supplier. Refer to each product page for its documented manufacturer or operator. Purchasing terms and ordering are available through your professional account.
The product list is temporarily unavailable.
Try againYour professional shop
Open the shop to sign in, view the terms available to your account and place your order.
Open the shop